Crowley, Jeffrey J.
Langley, Richard G.
Gordon, Kenneth B.
Pinter, Andreas
Ferris, Laura K.
Rubant, Simone
Photowala, Huzefa
Xue, Zhenyi
Wu, Tianshuang
Zhan, Tianyu
Beeck, Stefan
Shah, Megha
Warren, Richard B.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study
https://doi.org/10.1007/s13555-021-00679-6
Article History
Received: 5 November 2021
Accepted: 27 December 2021
First Online: 20 January 2022